Disease/Infection News

RSS

Are cattle at risk of SARS-CoV-2 infection?

Researchers evaluated antibodies targeting SARS-CoV-2 in cattle from farms in Germany.

3 Aug 2022

The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

Researchers evaluated all the features, especially the antigenic properties and transmission potential of SARS-CoV-2 Omicron sub-variant BA.2.75.

3 Aug 2022

Researchers implement standardized shunt infection prevention bundle within the adult population

Researchers at the University of Calgary, Alberta, Canada, investigated theimplementation of a standardized shunt infection prevention bundle, a set of evidence-based practices termed the Calgary Adult Shunt Infection Prevention Protocol (CASIPP) to prevent ventriculoperitoneal (VP) shunt infections within an adult hydrocephalus patient population. The initial implementation of the CASIPP resulted in infection reduction, and then the rate of infections was dramatically reduced after the preoperative skin antiseptic was replaced with 2% chlorhexidine gluconate in 70% isopropyl alcohol.

3 Aug 2022

Drugs with antiviral activity against monkeypox virus

In a recent study posted as an accepted manuscript in the journal Clinical Infectious Diseases, researchers from the University of Oklahoma described three drugs with antiviral activity against the monkeypox virus (MPXV).

2 Aug 2022

Study shows probability of getting COVID for mask wearers vs. non-mask wearers

In a recent study posted to the medRxiv* preprint server, researchers in the United States assessed the efficiency of facemasks in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) prevention.

2 Aug 2022

New and efficient method Monkeypox virus sequencing

In a recent study posted to the medRxiv* preprint server, Spanish researchers described a new enrichment method for metagenomic sequencing of the monkeypox virus (MPXV).

2 Aug 2022

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

Scientists hypothesize that the GNA affinity resin would remain effective against SARS-CoV-2 variants.

2 Aug 2022

High prevalence of fungal secondary infections among COVID-19 patients

Researchers analyze literature to explore the frequency of secondary fungal infections among COVID-19 patients.

2 Aug 2022

Further SARS-CoV-2 variants, and intermittent epidemics may become the 'new normal'

A new study explores the dynamics of the SARS-CoV-2 Omicron and other variants circulating in England.

2 Aug 2022

COVID pandemic stress and menstrual cycle changes

A new study explores the effect of the COVID-19 pandemic on women’s reproductive health.

2 Aug 2022

International travel restrictions were a key intervention for slowing COVID-19 spread, study shows

A study of COVID-19 variant transmission into and across Canada shows that international travel restrictions were a key intervention for reducing or slowing spread, according to a report published today in eLife.

2 Aug 2022

USF researchers launch a mosquito-tracking dashboard driven by citizen science

To combat the ongoing threat of mosquito-borne diseases worldwide, University of South Florida researchers have launched a mosquito-tracking dashboard driven by citizen science – a scalable solution proven effective in a recent USF study.

2 Aug 2022

Human anti-desmoglein 2 levels are associated with COVID-19 severity

In a new study, researchers assessed the association between anti-desmoglein (DSG) 1, 2 and 3 auto-antibodies (auto-Abs) in acute and convalescent serum samples obtained from patients with COVID-19 of varying severity.

2 Aug 2022

Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters

In a new study, researchers assessed the impact of pre-existing immunity against SARS-CoV-2 acquired by previous infections (PI) or COVID-19 vaccination on the transmission of SARS-CoV-2 variants of concern such as Delta and Omicron.

2 Aug 2022

Vaccination and BA.1 breakthrough infection induce neutralizing antibodies less efficient against BA.4 and BA.5 Omicron variants

A new study aimed to describe the appearance of the Omicron variants in Israel, from March to June 2022, as well as the neutralizing antibody response against the primary Omicron subvariants.

2 Aug 2022

How can researchers profile post-COVID syndromes among distinct SARS-CoV-2 variants?

In a new study, researchers profiled post-coronavirus disease (COVID) syndrome (PCS) throughout various SARS-CoV-2 variants.

2 Aug 2022

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

A new study monitored the safety of the second booster dose of SARS-CoV-2 messenger ribonucleic acid vaccination among those ≥50 Years.

2 Aug 2022

Lyme disease remains a growing public health concern in the United States, says FAIR Health study

Lyme disease has experienced notable growth in the United States over the past 15 years and, as a result, has become an illness of increasing national concern. From 2007 to 2021, private insurance claim lines with Lyme disease diagnoses rose 357 percent in rural areas and 65 percent in urban areas. These and other findings on this tick-borne, bacterial illness were captured in an infographic just released by FAIR Health. The national, independent organization used its database of over 36 billion privately billed healthcare claims to conduct its 15-year analysis of Lyme disease; this analysis builds upon a previous FAIR Health infographic that studied 10 years of Lyme disease data.

2 Aug 2022

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Researchers evaluated the differential humoral immune response to two COVID-19 vaccines - messenger ribonucleic acid (mRNA)-1273 and BNT162b2.

2 Aug 2022

Pediatric adjuvant formulation offers protection against RSV in newborns

Respiratory syncytial virus (RSV) is the leading global cause of death in children under age 5 and lacks an effective vaccine. In a study from the Precision Vaccines Program at Boston Children's Hospital, a new vaccine formulation protected newborn mice against infection and evoked strong responses in immune cells from human newborns in the laboratory. Results were reported August 2 in Nature Communications.

2 Aug 2022

Disease/Infection News

Are cattle at risk of SARS-CoV-2 infection?

The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

Researchers implement standardized shunt infection prevention bundle within the adult population

Drugs with antiviral activity against monkeypox virus

Study shows probability of getting COVID for mask wearers vs. non-mask wearers

New and efficient method Monkeypox virus sequencing

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

High prevalence of fungal secondary infections among COVID-19 patients

Further SARS-CoV-2 variants, and intermittent epidemics may become the 'new normal'

COVID pandemic stress and menstrual cycle changes

International travel restrictions were a key intervention for slowing COVID-19 spread, study shows

USF researchers launch a mosquito-tracking dashboard driven by citizen science

Human anti-desmoglein 2 levels are associated with COVID-19 severity

Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters

Vaccination and BA.1 breakthrough infection induce neutralizing antibodies less efficient against BA.4 and BA.5 Omicron variants

How can researchers profile post-COVID syndromes among distinct SARS-CoV-2 variants?

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

Lyme disease remains a growing public health concern in the United States, says FAIR Health study

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Pediatric adjuvant formulation offers protection against RSV in newborns

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News